A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor-Reference-Cited by-同舟云学术

A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor

Published:2020-06-17 Issue:34 Volume:59 Page:14609-14614
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Hanif Muhammad¹^ORCID,Arshad Jahanzaib¹,Astin Jonathan W.²,Rana Zohaib³,Zafar Ayesha¹,Movassaghi Sanam¹,Leung Euphemia⁴,Patel Kamal¹,Söhnel Tilo¹^ORCID,Reynisson Jóhannes⁵^ORCID,Sarojini Vijayalekshmi¹,Rosengren Rhonda J.³,Jamieson Stephen M. F.⁴^ORCID,Hartinger Christian G.¹^ORCID

Affiliation:

1. School of Chemical Sciences University of Auckland Private Bag 92019 Auckland 1142 New Zealand

2. School of Medical Sciences University of Auckland Private Bag 92019 Auckland 1142 New Zealand

3. Department of Pharmacology and Toxicology University of Otago Dunedin 9016 New Zealand

4. Auckland Cancer Society Research Centre University of Auckland Private Bag 92019 Auckland 1142 New Zealand

5. School of Pharmacy and Bioengineering Keele University Staffordshire ST5 5BG UK

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202005758

Reference54 articles.

2. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

3. Epigenetic therapy of cancer: past, present and future

4. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy;European Journal of Medicinal Chemistry;2024-11

2. Rhodium(III) Complex Noncanonically Potentiates Antitumor Immune Responses by Inhibiting Wnt/β-Catenin Signaling;Journal of Medicinal Chemistry;2024-08-12

3. Masking the Bioactivity of Hydroxamic Acids by Coordination to Cobalt: Towards Bioreductive Anticancer Agents;Chemistry – A European Journal;2024-07-26

4. A multifaceted approach towards organometallic anticancer agent development;Journal of Organometallic Chemistry;2024-05

5. Multinuclear Tin-Based Macrocyclic Organometallic Resist for EUV Photolithography;ACS Materials Au;2024-03-27